Health Care

  • Permalink Gallery

    The value of evidence in outcomes-based health care: an IMI BD4BO initiative

The value of evidence in outcomes-based health care: an IMI BD4BO initiative

At the European Health Forum Gastein on 5 October 2018, Big Data for Better Outcomes led a workshop on the value of evidence in outcomes-based healthcare. Shahid Hanif, Head of Health Data and Outcomes at the Association of the British Pharmaceutical Industry, represented DO->IT, the coordination and support action project of the Big Data for Better Outcomes programme. He […]

November 27th, 2018|Health Care, Methods|0 Comments|
  • Permalink Gallery

    Getting research into policy in health: The GRIP-Health project

Getting research into policy in health: The GRIP-Health project

by Justin Parkhurst

For many, the idea that health policy should be informed by evidence is an obvious goal. And indeed, the global health community has widely called for increased use or uptake of research and evidence, in health policymaking. However, a vast majority of these calls have been made without explicit recognition of the decidedly political nature of policymaking, […]

June 27th, 2017|Health Care|1 Comment|
  • Permalink Gallery

    Value in cancer drug spending: assessing the clinical risks and benefits from a decade’s worth of innovation

Value in cancer drug spending: assessing the clinical risks and benefits from a decade’s worth of innovation

by Sebastian Salas-Vega and Elias Mossialos

There are growing questions about the value from spending on what seem like ever-more expensive cancer medicines. Rising expenditures may make it difficult for patients to access or remain compliant with life-extending therapies. Yet, some have argued that high prices may be justified if new and innovative treatments offer significant clinical benefits. Even as […]

January 5th, 2017|Health Care|0 Comments|

Building a strong pharmaceutical system for China

by Elias Mossialos, Yanfeng Ge, Jia Hu and Liejun Wang

The world’s most populous country is facing a double healthcare crunch with a rapidly aging population and an explosion in the rate of non-communicable diseases such as diabetes, heart disease, and lung disease. Addressing these diseases will require a robust pharmaceutical system that is able to produce quality, effective, and […]

July 7th, 2016|Health Care|0 Comments|

Targeting innovation in antibiotics

by Matthew J Renwick, Victoria Simpkin and Elias Mossialos

Antimicrobial resistance (AMR) is currently responsible for over 700,000 deaths annually around the world. AMR mortality is predicted to rise exponentially to above 10 million deaths per year by 2050. The global economic cost of such a rise in mortality and morbidity is estimated to be $100 trillion.

Lack of innovation

Development of […]

July 1st, 2016|Health Care|0 Comments|

The changing role of nursing (New Eurohealth issue)

by Sherry Merkur, Anna Maresso and David McDaid
There is no doubt that the role of nurses has been changing over the past few decades, not only in terms of their evolving clinical and managerial responsibilities but also in terms of their education and training. These processes have been affected in many ways by developments at the European level, not […]

March 21st, 2016|Health Care|0 Comments|
  • Permalink Gallery

    Greater public investment is needed to fund the NHS at a level considered normal in other high income countries

Greater public investment is needed to fund the NHS at a level considered normal in other high income countries

by Philipa Mladovsky, Martin McKee, David Ingleby and Bernd Rechel

Health care is rarely far from the UK headlines, especially today, as junior doctors go on strike. The NHS’s failings are often highlighted prominently, its successes much less so. There is a constant stream of warnings that it is running out of money and thus unaffordable. Those who never liked […]

January 11th, 2016|Health Care|3 Comments|
  • Permalink Gallery

    Celebrating 10 years of “Health Economics, Policy and Law”

Celebrating 10 years of “Health Economics, Policy and Law”

by Adam Oliver

On 22 October 2015, LSE Health and Social Care and the LSE’s Department of Social Policy hosted a special event to mark the 10th anniversary of the Cambridge journal, Health Economics, Policy and Law (HEPL). Several of HEPL’s editorial board members delivered short presentations at the event, reflecting on issues that they thought posed particular challenges to the […]

January 6th, 2016|Health Care|0 Comments|

Are health care resources in the developed country context really scarce?

by Albert Weale

It is often said – indeed I have said it myself on a number of occasions – that the problem of the fair and efficient allocation of health care resources stems from the fact of scarcity. I should like to use the splendid and notable occasion of the tenth birthday party of Health Economics, Policy and Law […]

January 6th, 2016|Health Care, Hidden|0 Comments|

Health policy ideas fashionable in the Nordic countries

by Karsten Vrangbæk

Scandinavian policy studies have a long tradition of seeking inspiration from organizational theory. This has spurred an interest in concepts and solutions that become “fashionable” and travel across policy fields. They become “standard recipes” that policy makers and managers in health systems turn to, although the actual translation may differ across organizational settings. So what are some […]

January 6th, 2016|Health Care, Hidden|0 Comments|